Kiyomitsu Katsumata

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

Science advances

Antimicrobial agents and chemotherapy

Nature biomedical engineering

University of Chicago

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Chicago Aug 01 2017 - Jul 31 2019

United States

Visiting Scientist :: Pritzker School of Molecular Engineering

Publications

Eiji Yuba, Erica Budina, Kiyomitsu Katsumata, Ako Ishihara, Aslan Mansurov, Aaron T Alpar, Elyse A Watkins, Peyman Hosseinchi, Joseph W Reda, Abigail L Lauterbach, Mindy Nguyen, Ani Solanki, Takahiro Kageyama, Melody A Swartz, Jun Ishihara, Jeffrey A Hubbell
Suppression of Rheumatoid Arthritis by Enhanced Lymph Node Trafficking of Engineered Interleukin-10 in Murine Models. Arthritis & rheumatology (Hoboken, N.J.) 73 (5) (2021)
Jun Ishihara, Ako Ishihara, Koichi Sasaki, Steve Seung-Young Lee, John-Michael Williford, Mariko Yasui, Hiroyuki Abe, Lambert Potin, Peyman Hosseinchi, Kazuto Fukunaga, Michal M Rączy, Laura T Gray, Aslan Mansurov, Kiyomitsu Katsumata, Masashi Fukayama, Stephen J Kron, Melody A Swartz, Jeffrey A Hubbell
Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Science translational medicine 11 (487) (2020)
Ako Ishihara, Jun Ishihara, Elyse A Watkins, Andrew C Tremain, Mindy Nguyen, Ani Solanki, Kiyomitsu Katsumata, Aslan Mansurov, Erica Budina, Aaron T Alpar, Peyman Hosseinchi, Lea Maillat, Joseph W Reda, Takahiro Kageyama, Melody A Swartz, Eiji Yuba, Jeffrey A Hubbell
Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nature biomedical engineering 5 (5) (2020)
Kiyomitsu Katsumata, Jun Ishihara, Aslan Mansurov, Ako Ishihara, Michal M Rączy, Eiji Yuba, Jeffrey A Hubbell
Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies. Science advances 5 (11) (2019)
Ikuko Nakamura, Keisuke Ohsumi, Shinobu Takeda, Kiyomitsu Katsumata, Satoru Matsumoto, Souichiro Akamatsu, Hikaru Mitori, Toru Nakai
ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against Aspergillus Species through a Specific Transporter. Antimicrobial agents and chemotherapy 63 (10) (2019)

Kiyomitsu Katsumata.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kiyomitsu Katsumata